Pub Date : 2023-06-25DOI: 10.17802/2306-1278-2023-12-2-70-76
K. Klyshnikov, E. Ovcharenko, L. Barbarash
HighlightsThe «TiAra» bioprosthetic heart valves have better hemodynamic characteristics, such as higher effective orifice area and a lower mean pressure gradient.The «UniLine» bioprosthetic heart valve demonstrated better closing dynamic, expressed in a smaller regurgitation volume. Aim. To assess hydrodynamic characteristics of the «TiAra» bioprosthetic heart valve with flexible supporting frame compared with the classic stented «UniLine» bioprosthetic aortic valve.Methods. Using the Vivitro Pulse Duplicator (Vivitro Labs, Canada), we simulated the function of the heart via generating pulsatile flow to analyze bioprosthetic heart valves. To comprehensively assess the bioprosthesis function, three valves of each standard size (21, 23, 25 mm) were submitted to hydrodynamic testing, thus making a sample of nine bioprostheses of each model. The article provides the analysis of the effective orifice area, mean pressure gradient, regurgitation volume, and assessment of the statistical sensitivity of the parameters between groups at p = 0.05.Results. The assessment revealed that the «TiAra» bioprosthesis has bigger effective orifice area (p = 0.006) and lower mean pressure gradient (p = 0.02): 1.6–2.2 cm2 and 3.6–6.3 mmHg versus 1.08–1.73 cm2 and 4.8–12.1 mmHg, respectively. The regurgitation volume, however, was lower in the «UniLine» bioprostheses 0.8–4.1 mL/cycle versus 6.2–9.0 mL/cycle (p = 0.0004).Conclusion. Despite the fact that both studied models showed good hydrodynamic performance, the prosthesis with the flexible supporting frame («TiAra») showed better results regarding its effectiveness in vitro via presenting with bigger effective orifice area and lower mean pressure gradient. At the same time, the «UniLine» stented bioprosthesis had lower regurgitation volume, i.e. better closing dynamics.
{"title":"ADVANTAGES AND DISADVANTAGES OF HEART VALVE PROSTHESES WITH FLEXIBLE SUPPORTING FRAME COMPARED WITH THE CLASSIC STENTED PROSTHESES: EVALUATION OF THE HYDRODYNAMIC INDICATORS OF THE “UNILINE” AND “TIARA” BIOPROSTHESES","authors":"K. Klyshnikov, E. Ovcharenko, L. Barbarash","doi":"10.17802/2306-1278-2023-12-2-70-76","DOIUrl":"https://doi.org/10.17802/2306-1278-2023-12-2-70-76","url":null,"abstract":"HighlightsThe «TiAra» bioprosthetic heart valves have better hemodynamic characteristics, such as higher effective orifice area and a lower mean pressure gradient.The «UniLine» bioprosthetic heart valve demonstrated better closing dynamic, expressed in a smaller regurgitation volume. Aim. To assess hydrodynamic characteristics of the «TiAra» bioprosthetic heart valve with flexible supporting frame compared with the classic stented «UniLine» bioprosthetic aortic valve.Methods. Using the Vivitro Pulse Duplicator (Vivitro Labs, Canada), we simulated the function of the heart via generating pulsatile flow to analyze bioprosthetic heart valves. To comprehensively assess the bioprosthesis function, three valves of each standard size (21, 23, 25 mm) were submitted to hydrodynamic testing, thus making a sample of nine bioprostheses of each model. The article provides the analysis of the effective orifice area, mean pressure gradient, regurgitation volume, and assessment of the statistical sensitivity of the parameters between groups at p = 0.05.Results. The assessment revealed that the «TiAra» bioprosthesis has bigger effective orifice area (p = 0.006) and lower mean pressure gradient (p = 0.02): 1.6–2.2 cm2 and 3.6–6.3 mmHg versus 1.08–1.73 cm2 and 4.8–12.1 mmHg, respectively. The regurgitation volume, however, was lower in the «UniLine» bioprostheses 0.8–4.1 mL/cycle versus 6.2–9.0 mL/cycle (p = 0.0004).Conclusion. Despite the fact that both studied models showed good hydrodynamic performance, the prosthesis with the flexible supporting frame («TiAra») showed better results regarding its effectiveness in vitro via presenting with bigger effective orifice area and lower mean pressure gradient. At the same time, the «UniLine» stented bioprosthesis had lower regurgitation volume, i.e. better closing dynamics.","PeriodicalId":227108,"journal":{"name":"Complex Issues of Cardiovascular Diseases","volume":"74 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115555809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-25DOI: 10.17802/2306-1278-2023-12-2-144-155
O. Kamenskaya, A. Klinkova, I. Loginova, S. S. Porotnikova, I. I. Volkova, D. V. Habarov, V. V. Lomivorotov, V. Lomivorotov, A. Chernyavskiy
HighlightsThe article presents the analysis of anxiety and depressive disorders in patients who were followed as outpatients after surgery for chronic thromboembolic pulmonary hypertension in the long term, taking into account the study during the COVID–19 pandemic.The prevalence of clinically pronounced anxiety disorders in the group was 10.9%, depression - 18.6%, a combination of anxiety-depressive disorders was noted in 10.3% of cases.Multifactorial analysis revealed that the development of severe anxiety disorders in patients with chronic thromboembolic pulmonary hypertension in the long term is associated with a complicated postoperative course. Independent risk factors for clinically pronounced depressive disorders in these patients were older age, a history of cerebral circulation disorders, as well as pronounced post-COVID-19 functional disorders. Aim. To study the frequency and severity of anxiety-depressive disorders in patients with chronic thromboembolic pulmonary hypertension (CTEPH) in the long term after pulmonary thromboendarterectomy and to identify factors affecting their development.Methods. 156 patients with CTEPH were examined in the long term after surgery using the generalized anxiety disorder (GAD) questionnaire GAD-7 and the Beck`s Depression Inventory. In patients who suffered COVID-19, a “Post-COVID-19 Functional Status scale” (PCFS) was used to measure functional status over time after COVID-19. Logistic regression analysis was used to identify predictors of clinically pronounced GAD and depression in the long-term period after surgery.Results. In patients with CTEPH, clinically significant GAD and depression in the long term after surgery were observed in 10.9 and 18.6% of cases, respectively. A combination of anxiety and depressive disorders was noted in 10.3% of patients. The development of GAD was associated with cardiopulmonary insufficiency in the early postoperative period (ОR 3,1; CI 1,2–13,8; p = 0,009). Clinically pronounced depression was associated with older age (ОR 1,3; CI 1,04–2,0; p = 0,02), chronic cerebral circulatory insufficiency (ОR 7,6; CI 1,8–17,5; p = 0,02) and pronounced post-COVID-19 functional neurological disorders according to the PCFS scale (ОR 6,7; CI 1,9–14,5; p = 0,007). The combination of clinically expressed anxiety and depression was correlated with older age (ОR 1,1; CI 1,02–1,3; p = 0,04).Conclusion. The prevalence of clinically pronounced GAD in the group was 10.9%, depression was 18.6%, and a combination of anxiety and depressive disorders was noted in 10.3% of patients. The development of clinically significant GAD is associated with a complicated course of cardiac surgery. Independent risk factors for clinically significant depression were older age, a history of cerebral circulatory disorders and pronounced post-COVID-19 functional neurological disorders.
{"title":"ANXIETY-DEPRESSIVE SPECTRUM DISORDERS IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN THE LONG TERM AFTER SURGERY","authors":"O. Kamenskaya, A. Klinkova, I. Loginova, S. S. Porotnikova, I. I. Volkova, D. V. Habarov, V. V. Lomivorotov, V. Lomivorotov, A. Chernyavskiy","doi":"10.17802/2306-1278-2023-12-2-144-155","DOIUrl":"https://doi.org/10.17802/2306-1278-2023-12-2-144-155","url":null,"abstract":"HighlightsThe article presents the analysis of anxiety and depressive disorders in patients who were followed as outpatients after surgery for chronic thromboembolic pulmonary hypertension in the long term, taking into account the study during the COVID–19 pandemic.The prevalence of clinically pronounced anxiety disorders in the group was 10.9%, depression - 18.6%, a combination of anxiety-depressive disorders was noted in 10.3% of cases.Multifactorial analysis revealed that the development of severe anxiety disorders in patients with chronic thromboembolic pulmonary hypertension in the long term is associated with a complicated postoperative course. Independent risk factors for clinically pronounced depressive disorders in these patients were older age, a history of cerebral circulation disorders, as well as pronounced post-COVID-19 functional disorders. Aim. To study the frequency and severity of anxiety-depressive disorders in patients with chronic thromboembolic pulmonary hypertension (CTEPH) in the long term after pulmonary thromboendarterectomy and to identify factors affecting their development.Methods. 156 patients with CTEPH were examined in the long term after surgery using the generalized anxiety disorder (GAD) questionnaire GAD-7 and the Beck`s Depression Inventory. In patients who suffered COVID-19, a “Post-COVID-19 Functional Status scale” (PCFS) was used to measure functional status over time after COVID-19. Logistic regression analysis was used to identify predictors of clinically pronounced GAD and depression in the long-term period after surgery.Results. In patients with CTEPH, clinically significant GAD and depression in the long term after surgery were observed in 10.9 and 18.6% of cases, respectively. A combination of anxiety and depressive disorders was noted in 10.3% of patients. The development of GAD was associated with cardiopulmonary insufficiency in the early postoperative period (ОR 3,1; CI 1,2–13,8; p = 0,009). Clinically pronounced depression was associated with older age (ОR 1,3; CI 1,04–2,0; p = 0,02), chronic cerebral circulatory insufficiency (ОR 7,6; CI 1,8–17,5; p = 0,02) and pronounced post-COVID-19 functional neurological disorders according to the PCFS scale (ОR 6,7; CI 1,9–14,5; p = 0,007). The combination of clinically expressed anxiety and depression was correlated with older age (ОR 1,1; CI 1,02–1,3; p = 0,04).Conclusion. The prevalence of clinically pronounced GAD in the group was 10.9%, depression was 18.6%, and a combination of anxiety and depressive disorders was noted in 10.3% of patients. The development of clinically significant GAD is associated with a complicated course of cardiac surgery. Independent risk factors for clinically significant depression were older age, a history of cerebral circulatory disorders and pronounced post-COVID-19 functional neurological disorders.","PeriodicalId":227108,"journal":{"name":"Complex Issues of Cardiovascular Diseases","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125217864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-25DOI: 10.17802/2306-1278-2023-12-2
A. Sabetov, D. Sirota, Dmitry S. Hvan, Vsevolod A. Akulov, A. Chernyavskiy
HighlightsThe article outlines the modern concept of arterial myocardial revascularization, presents the most promising directions for development of coronary surgery, and describes the results and prospects of the clinical application of autogenous arterial grafts using two internal thoracic arteries in various graft configuration and in situ, making it possible to assess the effectiveness of the procedure. AbstractThere are many approaches to coronary artery bypass grafting with the internal thoracic arteries: the use of I and Y configuration, in situ grafts, and composite grafts. However, there is no consensus on the most effective type of configuration of arterial grafts. This is due to the complexity of making the composite Y graft, determination of the risk factor, and the lack of sufficient evidence regarding the main approaches to bypass grafting with autogenous arterial grafts.
{"title":"Arterial grafts for myocardial revascularization using the Y-composite grafts and the in situ internal thoracic artery conduits. The current status of the problem","authors":"A. Sabetov, D. Sirota, Dmitry S. Hvan, Vsevolod A. Akulov, A. Chernyavskiy","doi":"10.17802/2306-1278-2023-12-2","DOIUrl":"https://doi.org/10.17802/2306-1278-2023-12-2","url":null,"abstract":"HighlightsThe article outlines the modern concept of arterial myocardial revascularization, presents the most promising directions for development of coronary surgery, and describes the results and prospects of the clinical application of autogenous arterial grafts using two internal thoracic arteries in various graft configuration and in situ, making it possible to assess the effectiveness of the procedure. AbstractThere are many approaches to coronary artery bypass grafting with the internal thoracic arteries: the use of I and Y configuration, in situ grafts, and composite grafts. However, there is no consensus on the most effective type of configuration of arterial grafts. This is due to the complexity of making the composite Y graft, determination of the risk factor, and the lack of sufficient evidence regarding the main approaches to bypass grafting with autogenous arterial grafts. ","PeriodicalId":227108,"journal":{"name":"Complex Issues of Cardiovascular Diseases","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130301006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-25DOI: 10.17802/2306-1278-2023-12-2-163-172
A. Frolov, N. Zagorodnikov, S. Ivanov, R. Tarasov
HighlightsThe present study was conducted to evaluate in-hospital outcomes of one of the most effective and simultaneously controversial surgical techniques for myocardial revascularization using two internal thoracic arteries (ITA).To this date, this is the most complete analysis that has been carried out at the Research Institute on the topic of studying bilateral internal thoracic artery grafting (BITA). The results obtained are of great importance for the subsequent evaluation of long-term results. AbstractAim. To analyze in-hospital outcomes of BITA.Methods. The study included 232 patients who were admitted to the Cardiac Surgery Department for coronary artery bypass grafting (CABG). All patients were divided into 2 groups depending on the use of either single or bilateral ITA conduits. Both groups included equal number of patients – 116. In-hospital outcomes were analyzed.Results. BITA and CABG with single ITA were proven to be comparable regarding myocardial infarction, stroke, the need for percutaneous coronary intervention, death, and composite endpoint. At the same time BITA patients significantly more often had longer hospital stay and required inotropic drugs.Conclusion. BITA is a safe procedure comparable to classic CABG in terms of in-hospital complications, but at the same time, this intervention is associated with longer hospital stay, and extended inotropic drugs use.
{"title":"IN-HOSPITAL OUTCOMES OF BILATERAL INTERNAL MAMMARY ARTERY GRAFTING","authors":"A. Frolov, N. Zagorodnikov, S. Ivanov, R. Tarasov","doi":"10.17802/2306-1278-2023-12-2-163-172","DOIUrl":"https://doi.org/10.17802/2306-1278-2023-12-2-163-172","url":null,"abstract":"HighlightsThe present study was conducted to evaluate in-hospital outcomes of one of the most effective and simultaneously controversial surgical techniques for myocardial revascularization using two internal thoracic arteries (ITA).To this date, this is the most complete analysis that has been carried out at the Research Institute on the topic of studying bilateral internal thoracic artery grafting (BITA). The results obtained are of great importance for the subsequent evaluation of long-term results. AbstractAim. To analyze in-hospital outcomes of BITA.Methods. The study included 232 patients who were admitted to the Cardiac Surgery Department for coronary artery bypass grafting (CABG). All patients were divided into 2 groups depending on the use of either single or bilateral ITA conduits. Both groups included equal number of patients – 116. In-hospital outcomes were analyzed.Results. BITA and CABG with single ITA were proven to be comparable regarding myocardial infarction, stroke, the need for percutaneous coronary intervention, death, and composite endpoint. At the same time BITA patients significantly more often had longer hospital stay and required inotropic drugs.Conclusion. BITA is a safe procedure comparable to classic CABG in terms of in-hospital complications, but at the same time, this intervention is associated with longer hospital stay, and extended inotropic drugs use.","PeriodicalId":227108,"journal":{"name":"Complex Issues of Cardiovascular Diseases","volume":"177 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124396562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-25DOI: 10.17802/2306-1278-2023-12-2-173-182
R. Komarov, M. Nuzhdin, Vyacheslav A. Belov, S. V. Chernyavsky, A. M. Ismailbayev, O. Drakina, A.V. Tsaregorodtsev, Lusine R. Baziyants
HighlightsThe article presents the latest data on the techniques of implantation of the mitral homograft in the tricuspid position, and identifies groups of patients who are best suited for this method. Moreover, the article describes the evolution of this type of replacement, and highlights that many surgical techniques, although justified, require further study to show demonstrate their advantages. AbstractDespite the general trend in cardiac surgery towards valve-preserving interventions, valve replacements remain relevant, and the search for the perfect prosthetic valve continues. Many believe that tricuspid valve replacement using a mitral homograft can be the method of choice in certain situations. The analysis of the studies found in the PubMed database led the authors to the following conclusions: most of the data on the use of this technique in patients with infective endocarditis (IE), other indications are congenital heart disease (CHD) and rheumatic heart disease. Patients with IE who have undergone tricuspid valve replacement using a mitral homograft have good medium-term prospects, and respond well to medical treatment of recurrent IE. The mitral homograft in the tricuspid position remains intact even after prosthetic endocarditis. In this regard, it is possible to perform reconstructive intervention in case of prosthetic valve dysfunction without the need for repeated replacement. Such interventions are relevant for patients with growing heart for whom annuloplasty at the first stage of surgery is undesirable. Moreover, it is also cost-effective due to the high cost and low availability of homografts. The possibility of repeated tricuspid valve-in-valve replacement is important for patients who may not survive open surgery. To date, there are not enough long-term and short-term data on using a mitral homograft for tricuspid valve replacement, however, it can be assumed that the results of this technique will be positive provided that the appropriate implantation technique and strict patient selection are ensured. Many authors have come to the conclusion that the optimal homograft implantation technique includes sewing of the graft`s papillary muscles into the wall of the myocardium of the right ventricle (RV), fixating them on the outer surface of the RV, anatomical positioning of the homograft (anterior leaflet faces towards the IVS), and the use of an annuloplasty ring.
{"title":"Mitral homograft in tricuspid position: indications for implantation and surgical technique","authors":"R. Komarov, M. Nuzhdin, Vyacheslav A. Belov, S. V. Chernyavsky, A. M. Ismailbayev, O. Drakina, A.V. Tsaregorodtsev, Lusine R. Baziyants","doi":"10.17802/2306-1278-2023-12-2-173-182","DOIUrl":"https://doi.org/10.17802/2306-1278-2023-12-2-173-182","url":null,"abstract":"HighlightsThe article presents the latest data on the techniques of implantation of the mitral homograft in the tricuspid position, and identifies groups of patients who are best suited for this method. Moreover, the article describes the evolution of this type of replacement, and highlights that many surgical techniques, although justified, require further study to show demonstrate their advantages. AbstractDespite the general trend in cardiac surgery towards valve-preserving interventions, valve replacements remain relevant, and the search for the perfect prosthetic valve continues. Many believe that tricuspid valve replacement using a mitral homograft can be the method of choice in certain situations. The analysis of the studies found in the PubMed database led the authors to the following conclusions: most of the data on the use of this technique in patients with infective endocarditis (IE), other indications are congenital heart disease (CHD) and rheumatic heart disease. Patients with IE who have undergone tricuspid valve replacement using a mitral homograft have good medium-term prospects, and respond well to medical treatment of recurrent IE. The mitral homograft in the tricuspid position remains intact even after prosthetic endocarditis. In this regard, it is possible to perform reconstructive intervention in case of prosthetic valve dysfunction without the need for repeated replacement. Such interventions are relevant for patients with growing heart for whom annuloplasty at the first stage of surgery is undesirable. Moreover, it is also cost-effective due to the high cost and low availability of homografts. The possibility of repeated tricuspid valve-in-valve replacement is important for patients who may not survive open surgery. To date, there are not enough long-term and short-term data on using a mitral homograft for tricuspid valve replacement, however, it can be assumed that the results of this technique will be positive provided that the appropriate implantation technique and strict patient selection are ensured. Many authors have come to the conclusion that the optimal homograft implantation technique includes sewing of the graft`s papillary muscles into the wall of the myocardium of the right ventricle (RV), fixating them on the outer surface of the RV, anatomical positioning of the homograft (anterior leaflet faces towards the IVS), and the use of an annuloplasty ring.","PeriodicalId":227108,"journal":{"name":"Complex Issues of Cardiovascular Diseases","volume":"136 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130856755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-25DOI: 10.17802/2306-1278-2023-12-2-35-45
N. Lebedeva, Leonid K. Isakov, Margarita N. Sinkova, N. Tarasov, Lilia V. Kuznetsova
Highlights High cardiovascular morbidity and mortality in the Russian Federation and in Kuzbass is mainly due to high number of elderly and senile patients; it simply reflects the current demographic situation in the country. Elderly and senile patients with acute coronary syndrome (ACS) account for 50% of hospitalized patients. In real clinical practice, a significant number of elderly patients with ACS receive conservative treatment, whereas the prognosis in this cohort is determined by the development of recurrent coronary events and the progression of heart failure. Due to small number of patients older than 75-80 years included in randomized clinical trials, there are certain gaps in the management of elderly patients with ACS and heart failure. Obviously, elderly patients require a special approach to patient management, taking into account the complexity of clinical and anamnestic factors affecting the prognosis. AbstractAim. To study clinical and prognostic features of elderly patients with unstable angina pectoris undergoing conservative treatment depending on left ventricular ejection fraction (LVEF).Methods. 130 elderly patients, with mean age of 82 (77; 89) years, hospitalized for unstable angina with a GRACE score of less than 140 to a vascular center in Kemerovo were included in the study. During hospitalization, standard laboratory and instrumental studies were performed, except coronary angiography. The quality of life was assessed using the EQ-5D 3L questionnaire. After 12 months, patient compliance with treatment recommendations, primary and secondary endpoints, and quality of life were analyzed.Results. All patients were diagnosed with heart failure, 50 (38.5%) patients presented with LV EF less than 40% (the group I), 80 (61.5%) patients presented with LV EF more than 40% (the group II). The groups were comparable in gender, age, presence of multifocal of atherosclerotic disease, prevalence of aortic stenosis, arrhythmias and comorbidities. Women predominated in both groups, and arterial hypertension was noted in all patients. In the group I, a history of myocardial infarction, coronary revascularization, and NYHA FC III were more common (p<0.05). The level of quality of life at discharge was low in both groups: 34.8 (29; 42) and 39.4 (34; 46) points, respectively (p>0.05). Almost all patients were on triple neurohumoral blockade (beta-blockers, renin-angiotensin-aldosterone system inhibitors and mineralocorticoid receptor antagonists) for heart failure and dual antiplatelet therapy. One year later, 85.2% of patients in the group I and 90% of patients in the group II were taking all prescribed medication at low or medium therapeutic doses (without the need for drug titration). The overall mortality in the groups was 46% and 37.5%; cardiovascular deaths accounted for 32% and 30%, respectively (p>0.05). There were no differences in the frequency of endpoints (hospitalization, stroke, acute coronary syndrome, coronary revasculari
{"title":"CLINICAL AND PROGNOSTIC FEATURES OF ELDERLY PATIENTS WITH UNSTABLE ANGINA PECTORIS UNDERGOING CONSERVATIVE TREATMENT DEPENDING ON LEFT VENTRICULAR EJECTION FRACTION","authors":"N. Lebedeva, Leonid K. Isakov, Margarita N. Sinkova, N. Tarasov, Lilia V. Kuznetsova","doi":"10.17802/2306-1278-2023-12-2-35-45","DOIUrl":"https://doi.org/10.17802/2306-1278-2023-12-2-35-45","url":null,"abstract":"Highlights High cardiovascular morbidity and mortality in the Russian Federation and in Kuzbass is mainly due to high number of elderly and senile patients; it simply reflects the current demographic situation in the country. Elderly and senile patients with acute coronary syndrome (ACS) account for 50% of hospitalized patients. In real clinical practice, a significant number of elderly patients with ACS receive conservative treatment, whereas the prognosis in this cohort is determined by the development of recurrent coronary events and the progression of heart failure. Due to small number of patients older than 75-80 years included in randomized clinical trials, there are certain gaps in the management of elderly patients with ACS and heart failure. Obviously, elderly patients require a special approach to patient management, taking into account the complexity of clinical and anamnestic factors affecting the prognosis. AbstractAim. To study clinical and prognostic features of elderly patients with unstable angina pectoris undergoing conservative treatment depending on left ventricular ejection fraction (LVEF).Methods. 130 elderly patients, with mean age of 82 (77; 89) years, hospitalized for unstable angina with a GRACE score of less than 140 to a vascular center in Kemerovo were included in the study. During hospitalization, standard laboratory and instrumental studies were performed, except coronary angiography. The quality of life was assessed using the EQ-5D 3L questionnaire. After 12 months, patient compliance with treatment recommendations, primary and secondary endpoints, and quality of life were analyzed.Results. All patients were diagnosed with heart failure, 50 (38.5%) patients presented with LV EF less than 40% (the group I), 80 (61.5%) patients presented with LV EF more than 40% (the group II). The groups were comparable in gender, age, presence of multifocal of atherosclerotic disease, prevalence of aortic stenosis, arrhythmias and comorbidities. Women predominated in both groups, and arterial hypertension was noted in all patients. In the group I, a history of myocardial infarction, coronary revascularization, and NYHA FC III were more common (p<0.05). The level of quality of life at discharge was low in both groups: 34.8 (29; 42) and 39.4 (34; 46) points, respectively (p>0.05). Almost all patients were on triple neurohumoral blockade (beta-blockers, renin-angiotensin-aldosterone system inhibitors and mineralocorticoid receptor antagonists) for heart failure and dual antiplatelet therapy. One year later, 85.2% of patients in the group I and 90% of patients in the group II were taking all prescribed medication at low or medium therapeutic doses (without the need for drug titration). The overall mortality in the groups was 46% and 37.5%; cardiovascular deaths accounted for 32% and 30%, respectively (p>0.05). There were no differences in the frequency of endpoints (hospitalization, stroke, acute coronary syndrome, coronary revasculari","PeriodicalId":227108,"journal":{"name":"Complex Issues of Cardiovascular Diseases","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128495638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-25DOI: 10.17802/2306-1278-2023-12-2-183-188
A. Y. Serdechnaya, I. Sukmanova
HighlightsThis clinical case describes the management of a 29 weeks pregnant patient with myocardial infarction. The material will be useful for cardiologists, physicians, obstetricians and gynecologists, and endovascular surgeons. AbstractUnavoidable drastic changes in lifestyle due childbirth are pushing women to postpone it to an older age, thus increasing the risk of coronary artery disease (CAD) in pregnant women. This can be a problem not only for patients, but also for specialists. Currently there are 3-6 cases of acute coronary syndrome (ACS) per 100 thousand pregnancies, meaning such cases occur rarely in real clinical practice. Discomfort in the chest area does not directly indicate cardiac problem, so women do not visit cardiologist right away, and thus ACS remains undiagnosed. Besides traditional risk factors for CAD (age, dyslipidemia, smoking, physical inactivity), there are some additional obstetric factors: preeclampsia, thrombophilia and postpartum bleeding. About 40% of patients have myocardial infarction in the third trimester. Atherosclerosis is the most common cause of ACS, with coronary artery spasms, coronary artery dissection and thrombosis following behind. Currently the maternal mortality due to MI has decreased from 20% to 5% due to introduction of the percutaneous coronary intervention (PCI) into the treatment of ACS. There are not enough data on the use of thrombolytics and other medicine in the treatment of CAD, because pharmacological therapy can be dangerous in the early pregnancy at the peak of organogenesis. Moreover, PCI should be used with caution due to harmful effects of radiation on the pregnant woman and the fetus. The main task in later stages of pregnancy is to balance out the risk of stent thrombosis upon discontinuing double antiplatelet therapy and bleeding during childbirth and in the postpartum period. This article describes a clinical case of a 29 weeks pregnant patient with myocardial infarction.
{"title":"Clinical case of a 29 weeks pregnant patient with ST-segment elevation myocardial infarction","authors":"A. Y. Serdechnaya, I. Sukmanova","doi":"10.17802/2306-1278-2023-12-2-183-188","DOIUrl":"https://doi.org/10.17802/2306-1278-2023-12-2-183-188","url":null,"abstract":"HighlightsThis clinical case describes the management of a 29 weeks pregnant patient with myocardial infarction. The material will be useful for cardiologists, physicians, obstetricians and gynecologists, and endovascular surgeons. AbstractUnavoidable drastic changes in lifestyle due childbirth are pushing women to postpone it to an older age, thus increasing the risk of coronary artery disease (CAD) in pregnant women. This can be a problem not only for patients, but also for specialists. Currently there are 3-6 cases of acute coronary syndrome (ACS) per 100 thousand pregnancies, meaning such cases occur rarely in real clinical practice. Discomfort in the chest area does not directly indicate cardiac problem, so women do not visit cardiologist right away, and thus ACS remains undiagnosed. Besides traditional risk factors for CAD (age, dyslipidemia, smoking, physical inactivity), there are some additional obstetric factors: preeclampsia, thrombophilia and postpartum bleeding. About 40% of patients have myocardial infarction in the third trimester. Atherosclerosis is the most common cause of ACS, with coronary artery spasms, coronary artery dissection and thrombosis following behind. Currently the maternal mortality due to MI has decreased from 20% to 5% due to introduction of the percutaneous coronary intervention (PCI) into the treatment of ACS. There are not enough data on the use of thrombolytics and other medicine in the treatment of CAD, because pharmacological therapy can be dangerous in the early pregnancy at the peak of organogenesis. Moreover, PCI should be used with caution due to harmful effects of radiation on the pregnant woman and the fetus. The main task in later stages of pregnancy is to balance out the risk of stent thrombosis upon discontinuing double antiplatelet therapy and bleeding during childbirth and in the postpartum period. This article describes a clinical case of a 29 weeks pregnant patient with myocardial infarction.","PeriodicalId":227108,"journal":{"name":"Complex Issues of Cardiovascular Diseases","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130794431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-25DOI: 10.17802/2306-1278-2023-12-2-189-195
R. Muratov, A. G. Khramchenkov, D. Titov, S. Babenko, Georgy A. Khugaev
HighlightsIntravascular leiomyoma with heart extension is a rare occurring condition. According to the available data, the number of cases does not exceed 30 despite many years of studies. Often cardiac hospitals cannot establish the clinical picture, so the surgeon removes only cardiac tumors, which inevitably leads to the recurrence of the tumor after a few months. AbstractLeiomyomatosis is an extremely rare disease that occurs in women of childbearing age. The development of the malignant tumor is preceded by the removal of the uterine fibroids or hysterectomy. Radical surgery guarantees the complete absence of relapses, while partial removal leads to relapses in a third of cases. We performed a reoperation on a 35-year-old patient who underwent partial removal of leiomyoma in the right atrium but 3 months later had a tumor causing severe obstruction of the right heart.
{"title":"COMBINED SURGERY IN A PATIENT WITH INTRACARDIAC LEIOMYOMATOSIS: A CLINICAL CASE","authors":"R. Muratov, A. G. Khramchenkov, D. Titov, S. Babenko, Georgy A. Khugaev","doi":"10.17802/2306-1278-2023-12-2-189-195","DOIUrl":"https://doi.org/10.17802/2306-1278-2023-12-2-189-195","url":null,"abstract":"HighlightsIntravascular leiomyoma with heart extension is a rare occurring condition. According to the available data, the number of cases does not exceed 30 despite many years of studies. Often cardiac hospitals cannot establish the clinical picture, so the surgeon removes only cardiac tumors, which inevitably leads to the recurrence of the tumor after a few months. AbstractLeiomyomatosis is an extremely rare disease that occurs in women of childbearing age. The development of the malignant tumor is preceded by the removal of the uterine fibroids or hysterectomy. Radical surgery guarantees the complete absence of relapses, while partial removal leads to relapses in a third of cases. We performed a reoperation on a 35-year-old patient who underwent partial removal of leiomyoma in the right atrium but 3 months later had a tumor causing severe obstruction of the right heart.","PeriodicalId":227108,"journal":{"name":"Complex Issues of Cardiovascular Diseases","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114084466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-25DOI: 10.17802/2306-1278-2023-12-2-88-95
A. Sabetov, D. Sirota, Dmitry S. Hvan, Vsevolod A. Akulov, A. Chernyavskiy
HighlightsThe article outlines the modern concept of arterial myocardial revascularization, presents the most promising directions for development of coronary surgery, and describes the results and prospects of the clinical application of autogenous arterial grafts using two internal thoracic arteries in various graft configuration and in situ, making it possible to assess the effectiveness of the procedure. AbstractThere are many approaches to coronary artery bypass grafting with the internal thoracic arteries: the use of I and Y configuration, in situ grafts, and composite grafts. However, there is no consensus on the most effective type of configuration of arterial grafts. This is due to the complexity of making the composite Y graft, determination of the risk factor, and the lack of sufficient evidence regarding the main approaches to bypass grafting with autogenous arterial grafts.
{"title":"AUTOGENOUS ARTERIAL GRAFTS FOR MYOCARDIAL REVASCULARIZATION USING THE Y-COMPOSITE GRAFTS AND THE IN SITU INTERNAL THORACIC ARTERY CONDUITS. THE CURRENT STATUS OF THE PROBLEM","authors":"A. Sabetov, D. Sirota, Dmitry S. Hvan, Vsevolod A. Akulov, A. Chernyavskiy","doi":"10.17802/2306-1278-2023-12-2-88-95","DOIUrl":"https://doi.org/10.17802/2306-1278-2023-12-2-88-95","url":null,"abstract":"HighlightsThe article outlines the modern concept of arterial myocardial revascularization, presents the most promising directions for development of coronary surgery, and describes the results and prospects of the clinical application of autogenous arterial grafts using two internal thoracic arteries in various graft configuration and in situ, making it possible to assess the effectiveness of the procedure. AbstractThere are many approaches to coronary artery bypass grafting with the internal thoracic arteries: the use of I and Y configuration, in situ grafts, and composite grafts. However, there is no consensus on the most effective type of configuration of arterial grafts. This is due to the complexity of making the composite Y graft, determination of the risk factor, and the lack of sufficient evidence regarding the main approaches to bypass grafting with autogenous arterial grafts. ","PeriodicalId":227108,"journal":{"name":"Complex Issues of Cardiovascular Diseases","volume":"92 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124573537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-25DOI: 10.17802/2306-1278-2023-12-2-57-69
I. Khalivopulo, A. Evtushenko, A. Shabaldin, N. Troshkinev, A. Stasev, S. G. Kokorin, L. Barbarash
HighlightsThe article describes the first conducted pseudorandomized comparative study of mitral valve replacement using either traditional or “valve-in-valve” techniques. AbstractAim. To compare short-term (perioperative) and medium-term (6 months) outcomes of surgical treatment of bioprosthetic mitral valve dysfunction using traditional and “valve-in-valve” methods.Methods. The study included 18 patients undergoing “valve-in-valve” replacement and 18 patients undergoing traditional mitral valve replacement (open mitral valve replacement) chosen according to the following criteria: heart disease type, predominant type of defect, age, gender, severity of the disease and the presence of concomitant pathology and using 1:1 matching on the propensity score.Results. No perioperative mortality was noted in both groups. The cardiopulmonary bypass and cross-clamping of the aorta time was significantly lower in the “valve-in-valve” group. Comparison of echocardiographic parameters revealed a decrease in the mean pulmonary arterial pressure gradient, and a decrease in the size of the heart chambers in both groups. The peak and mean transvalvular gradient were lower in the “traditional” group. There were no cases of patient-prosthesis mismatch. In the mid-term period, patients in both groups presented with a lower functional class of heart failure.Conclusion. Bioprosthetic mitral valve replacement using the “valve-in-valve” technique provides comparable clinical and hemodynamic results compared to the “traditional” technique in short-term and mid-term periods, and significantly reduces cardiopulmonary bypass and aortic cross clamping time.
{"title":"COMPARISON OF PROPENSITY SCORES FOR SURGICAL TREATMENT OF BIOPROSTHETIC MITRAL VALVE DYSFUNCTION USING TRADITIONAL AND “VALVE-IN-VALVE” METHODS","authors":"I. Khalivopulo, A. Evtushenko, A. Shabaldin, N. Troshkinev, A. Stasev, S. G. Kokorin, L. Barbarash","doi":"10.17802/2306-1278-2023-12-2-57-69","DOIUrl":"https://doi.org/10.17802/2306-1278-2023-12-2-57-69","url":null,"abstract":"HighlightsThe article describes the first conducted pseudorandomized comparative study of mitral valve replacement using either traditional or “valve-in-valve” techniques. AbstractAim. To compare short-term (perioperative) and medium-term (6 months) outcomes of surgical treatment of bioprosthetic mitral valve dysfunction using traditional and “valve-in-valve” methods.Methods. The study included 18 patients undergoing “valve-in-valve” replacement and 18 patients undergoing traditional mitral valve replacement (open mitral valve replacement) chosen according to the following criteria: heart disease type, predominant type of defect, age, gender, severity of the disease and the presence of concomitant pathology and using 1:1 matching on the propensity score.Results. No perioperative mortality was noted in both groups. The cardiopulmonary bypass and cross-clamping of the aorta time was significantly lower in the “valve-in-valve” group. Comparison of echocardiographic parameters revealed a decrease in the mean pulmonary arterial pressure gradient, and a decrease in the size of the heart chambers in both groups. The peak and mean transvalvular gradient were lower in the “traditional” group. There were no cases of patient-prosthesis mismatch. In the mid-term period, patients in both groups presented with a lower functional class of heart failure.Conclusion. Bioprosthetic mitral valve replacement using the “valve-in-valve” technique provides comparable clinical and hemodynamic results compared to the “traditional” technique in short-term and mid-term periods, and significantly reduces cardiopulmonary bypass and aortic cross clamping time.","PeriodicalId":227108,"journal":{"name":"Complex Issues of Cardiovascular Diseases","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131053271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：